AI Engines For more Details: Perplexity Kagi Labs You
Anxiolytic Effects: Ipsapirone has been studied for its anxiolytic properties, meaning it may help reduce symptoms of anxiety. It is believed to work by modulating serotonin levels in the brain, which can affect mood and anxiety levels.
Antidepressant Effects: Like other serotonin receptor agonists, ipsapirone has been investigated for its potential antidepressant effects. By modulating serotonin signaling, it may help alleviate symptoms of depression in some individuals.
Side Effects: Common side effects associated with ipsapirone use may include dizziness, drowsiness, headache, nausea, and gastrointestinal disturbances. These side effects are typically mild and transient.
Cardiovascular Effects: Ipsapirone may cause changes in heart rate and blood pressure in some individuals. It is important for individuals with cardiovascular conditions to use ipsapirone cautiously and under medical supervision.
Interactions: Ipsapirone may interact with other medications, particularly those that affect serotonin levels in the brain, such as selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), and tricyclic antidepressants (TCAs). Combining ipsapirone with these medications may increase the risk of serotonin syndrome, a potentially life-threatening condition characterized by changes in mental status, autonomic dysfunction, and neuromuscular abnormalities.
Withdrawal: Abrupt discontinuation of ipsapirone after long-term use may lead to withdrawal symptoms such as anxiety, insomnia, agitation, and flu-like symptoms. It is recommended to taper off the medication gradually under medical supervision to minimize withdrawal effects.
Liver Function: Ipsapirone may affect liver function, so individuals with pre-existing liver conditions should use it with caution and under medical supervision.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Faecalibacterium prausnitzii | Reduces |
species | Parabacteroides distasonis | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Olsenella | genus | Decreases |
0 | 1 | Pseudobutyrivibrio | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Fannyhessea | genus | Decreases |
0 | 1 | Faecalibaculum | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Faecalibacterium prausnitzii | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Alistipes senegalensis | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Lachnospira eligens | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Romboutsia sp. 13368 | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Alistipes communis | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Alistipes shahii | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Intestinimonas butyriciproducens | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.3 | 0.3 | |
Acne | 0.1 | -0.1 | |
ADHD | 1.9 | 0.6 | 2.17 |
Age-Related Macular Degeneration and Glaucoma | 0.9 | 0 | 0 |
Allergic Rhinitis (Hay Fever) | 1.8 | 1.6 | 0.13 |
Allergies | 4.3 | 2.5 | 0.72 |
Allergy to milk products | 1.4 | 0.6 | 1.33 |
Alopecia (Hair Loss) | 1.1 | 0.1 | 10 |
Alzheimer's disease | 4.7 | 4.1 | 0.15 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.3 | 0.8 | 1.87 |
Ankylosing spondylitis | 2.6 | 0.7 | 2.71 |
Anorexia Nervosa | 0.6 | 1.5 | -1.5 |
Antiphospholipid syndrome (APS) | 0.5 | 0.2 | 1.5 |
Asthma | 3.5 | 2.4 | 0.46 |
Atherosclerosis | 1.5 | 1.5 | 0 |
Atrial fibrillation | 1.6 | 1 | 0.6 |
Autism | 6.5 | 5.5 | 0.18 |
Autoimmune Disease | 0.2 | 0.6 | -2 |
Barrett esophagus cancer | 0.4 | 0 | 0 |
benign prostatic hyperplasia | 0.1 | 0.2 | -1 |
Biofilm | 1.2 | 1.2 | |
Bipolar Disorder | 1.1 | 0.8 | 0.38 |
Brain Trauma | 0.5 | 0.7 | -0.4 |
Breast Cancer | 0.6 | 0.6 | |
Cancer (General) | 0.6 | 1.5 | -1.5 |
Carcinoma | 2.6 | 1.4 | 0.86 |
Celiac Disease | 1.5 | 2.1 | -0.4 |
Cerebral Palsy | 1.2 | 0.7 | 0.71 |
Chronic Fatigue Syndrome | 3.2 | 4.2 | -0.31 |
Chronic Kidney Disease | 3 | 1.9 | 0.58 |
Chronic Lyme | 0.2 | 0.5 | -1.5 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.7 | 0.7 | 0 |
Chronic Urticaria (Hives) | 0.7 | 1.2 | -0.71 |
Coagulation / Micro clot triggering bacteria | 0.4 | 0.7 | -0.75 |
Cognitive Function | 1.1 | 0.8 | 0.38 |
Colorectal Cancer | 3.9 | 1.5 | 1.6 |
Constipation | 0.5 | 0.5 | 0 |
Coronary artery disease | 1.2 | 1.9 | -0.58 |
COVID-19 | 6.6 | 8.9 | -0.35 |
Crohn's Disease | 5.2 | 3.9 | 0.33 |
Cushing's Syndrome (hypercortisolism) | 0.4 | -0.4 | |
cystic fibrosis | 0.3 | 1.2 | -3 |
d-lactic acidosis (one form of brain fog) | 0.2 | 0.2 | |
deep vein thrombosis | 1.4 | 0.6 | 1.33 |
Denture Wearers Oral Shifts | 1 | 1 | |
Depression | 6.5 | 5.3 | 0.23 |
Dermatomyositis | 0 | 0.1 | 0 |
Eczema | 1.1 | 0.9 | 0.22 |
Endometriosis | 1.6 | 0.9 | 0.78 |
Eosinophilic Esophagitis | 0.2 | 0.2 | 0 |
Epilepsy | 2.7 | 1.7 | 0.59 |
erectile dysfunction | 0.6 | 0.1 | 5 |
Fibromyalgia | 1.9 | 1.2 | 0.58 |
Functional constipation / chronic idiopathic constipation | 2.3 | 2.4 | -0.04 |
gallstone disease (gsd) | 1.9 | 1.1 | 0.73 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.3 | 1.1 | 0.18 |
Generalized anxiety disorder | 2.1 | 1 | 1.1 |
giant cell arteritis | 0.2 | -0.2 | |
Glioblastoma | 0 | 0 | |
Gout | 2 | 0.7 | 1.86 |
Graves' disease | 0.8 | 1.9 | -1.37 |
Gulf War Syndrome | 0.4 | 1.5 | -2.75 |
Halitosis | 1 | 0 | 0 |
Hashimoto's thyroiditis | 2.6 | 1.2 | 1.17 |
Heart Failure | 1.7 | 1.7 | 0 |
hemorrhagic stroke | 0.6 | 0.6 | |
Hidradenitis Suppurativa | 0.6 | 0.2 | 2 |
High Histamine/low DAO | 1 | 0.1 | 9 |
hypercholesterolemia (High Cholesterol) | 0.6 | 0.6 | 0 |
hyperglycemia | 1 | 1.8 | -0.8 |
Hyperlipidemia (High Blood Fats) | 1.1 | 0.2 | 4.5 |
hypersomnia | 0.7 | -0.7 | |
hypertension (High Blood Pressure | 2.7 | 3.4 | -0.26 |
Hypothyroidism | 0.5 | 0.7 | -0.4 |
Hypoxia | 1.7 | 1.7 | |
IgA nephropathy (IgAN) | 0.8 | 2.7 | -2.38 |
Inflammatory Bowel Disease | 6.2 | 6.4 | -0.03 |
Insomnia | 1.3 | 2.2 | -0.69 |
Intelligence | 0.8 | 0.4 | 1 |
Intracranial aneurysms | 0.7 | 0.2 | 2.5 |
Irritable Bowel Syndrome | 5.5 | 3.2 | 0.72 |
ischemic stroke | 1.1 | 0.8 | 0.38 |
Juvenile idiopathic arthritis | 0.1 | 0.1 | |
Liver Cirrhosis | 4.7 | 3.3 | 0.42 |
Long COVID | 4.7 | 4.9 | -0.04 |
Low bone mineral density | 0.6 | -0.6 | |
Lung Cancer | 1 | 1.5 | -0.5 |
Lymphoma | 0.1 | 0.1 | |
Mast Cell Issues / mastitis | 0.5 | 0.1 | 4 |
ME/CFS with IBS | 0.2 | 2.2 | -10 |
ME/CFS without IBS | 1.7 | 1.6 | 0.06 |
membranous nephropathy | 0 | 0 | |
Menopause | 1.2 | 0.9 | 0.33 |
Metabolic Syndrome | 5.7 | 5.3 | 0.08 |
Mood Disorders | 7.2 | 3.9 | 0.85 |
multiple chemical sensitivity [MCS] | 0.8 | 0.4 | 1 |
Multiple Sclerosis | 4.9 | 3.2 | 0.53 |
Multiple system atrophy (MSA) | 1.7 | 0.4 | 3.25 |
myasthenia gravis | 0.1 | 0.4 | -3 |
neuropathic pain | 0.3 | 2.1 | -6 |
Neuropathy (all types) | 1.1 | 1 | 0.1 |
neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.5 | 3.6 | -0.03 |
NonCeliac Gluten Sensitivity | 1.7 | 0.3 | 4.67 |
Obesity | 8.1 | 5.9 | 0.37 |
obsessive-compulsive disorder | 2.8 | 2.6 | 0.08 |
Osteoarthritis | 1.6 | 1.1 | 0.45 |
Osteoporosis | 1.3 | 1.6 | -0.23 |
pancreatic cancer | 0.6 | 0 | 0 |
Parkinson's Disease | 5.9 | 3.7 | 0.59 |
Polycystic ovary syndrome | 2.9 | 1.9 | 0.53 |
Postural orthostatic tachycardia syndrome | 0.2 | 0.1 | 1 |
Premenstrual dysphoric disorder | 0.6 | 0 | 0 |
primary biliary cholangitis | 0.6 | 0.7 | -0.17 |
Primary sclerosing cholangitis | 1.4 | 1.8 | -0.29 |
Psoriasis | 2.7 | 1.7 | 0.59 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.9 | 2.8 | 0.75 |
Rosacea | 0.3 | 0.6 | -1 |
Schizophrenia | 4.1 | 1.7 | 1.41 |
scoliosis | 0.4 | 0.3 | 0.33 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 1.8 | 1.6 | 0.13 |
Sleep Apnea | 0.9 | 1.1 | -0.22 |
Slow gastric motility / Gastroparesis | 0.6 | 0.1 | 5 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1 | 0.1 | 9 |
Stress / posttraumatic stress disorder | 2.1 | 2.2 | -0.05 |
Systemic Lupus Erythematosus | 2.5 | 1.1 | 1.27 |
Tic Disorder | 0.5 | 1.3 | -1.6 |
Tourette syndrome | 0.9 | 0.2 | 3.5 |
Type 1 Diabetes | 2.7 | 1.8 | 0.5 |
Type 2 Diabetes | 5.7 | 4.3 | 0.33 |
Ulcerative colitis | 3.4 | 4.8 | -0.41 |
Unhealthy Ageing | 3 | 1.4 | 1.14 |
Vitiligo | 0.6 | 1.1 | -0.83 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]